Repeated Ketamine Exposure Induces an Enduring Resilient Phenotype in Adolescent and Adult Rats

被引:96
作者
Parise, Eric M.
Alcantara, Lyonna F.
Warren, Brandon L.
Wright, Katherine N.
Hadad, Roey
Sial, Omar K.
Kroeck, Kyle G.
Iniguez, Sergio D.
Bolanos-Guzman, Carlos A. [1 ,2 ]
机构
[1] Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA
[2] Florida State Univ, Program Neurosci, Tallahassee, FL 32306 USA
关键词
Adolescence; anxiety; depression; ketamine; rats; resilience; stress; CONDITIONED PLACE PREFERENCE; CHRONIC MILD STRESS; SEROTONIN REUPTAKE INHIBITORS; RESISTANT MAJOR DEPRESSION; NMDA RECEPTOR BLOCKADE; D-ASPARTATE ANTAGONIST; BEHAVIORAL-RESPONSES; MOOD DISORDERS; RHESUS-MONKEYS; ANIMAL-MODELS;
D O I
10.1016/j.biopsych.2013.04.027
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Major depressive disorder afflicts up to 10% of adolescents. However, nearly 50% of those afflicted are considered nonresponsive to available treatments. Ketamine, a noncompetitive N-methyl-D-aspartate receptor antagonist has shown potential as a rapid-acting and long-lasting treatment for major depressive disorder in adults. Thus, the effectiveness and functional consequences of ketamine exposure during adolescence were explored. Methods: Adolescent male rats (postnatal day [PD] 35) received two ketamine (0, 5, 10, or 20 mg/kg) injections, 4 hours apart, after exposure to day 1 of the forced swim test (FST). The next day, rats were reexposed to the FST to assess ketamine-induced antidepressant-like responses. Separate groups were exposed to chronic unpredictable stress to confirm findings from the FST. After these initial experiments, adolescent naive rats were exposed to either 1 or 15 consecutive days (PD35-49) of ketamine (20 mg/kg) twice daily. Ketamine's influence on behavioral reactivity to rewarding (i.e., sucrose preference) and aversive (i.e., elevated plus-maze, FST) circumstances was then assessed 2 months after treatment. To control for age-dependent effects, adult rats (PD75-89) were exposed to identical experimental conditions. Results: Ketamine (20 mg/kg) reversed the chronic unpredictable stress-induced depression-like behaviors in the FST. Repeated ketamine exposure resulted in anxiolytic- and antidepressant-like responses 2 months after drug exposure. None of the ketamine doses used were capable of inducing drug-seeking behaviors as measured by place preference conditioning. Conclusions: Repeated ketamine exposure induces enduring resilient-like responses regardless of age of exposure. These findings point to ketamine, and its repeated exposure, as a potentially useful antidepressant during adolescence.
引用
收藏
页码:750 / 759
页数:10
相关论文
共 94 条
[1]   Ketamine for Depression: Where Do We Go from Here? [J].
Aan Het Rot, Marije ;
Zarate, Carlos A., Jr. ;
Charney, Dennis S. ;
Mathew, Sanjay J. .
BIOLOGICAL PSYCHIATRY, 2012, 72 (07) :537-547
[2]   Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression [J].
aan het Rot, Marije ;
Collins, Katherine A. ;
Murrough, James W. ;
Perez, Andrew M. ;
Reich, David L. ;
Charney, Dennis S. ;
Mathew, Sanjay J. .
BIOLOGICAL PSYCHIATRY, 2010, 67 (02) :139-145
[3]  
ADAMS HA, 1992, ANAESTHESIST, V41, P588
[4]   Stimulants and the developing brain [J].
Andersen, SL .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2005, 26 (05) :237-243
[5]   Altering the course of neurodevelopment: a framework for understanding the enduring effects of psychotropic drugs [J].
Andersen, SL ;
Navalta, CP .
INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE, 2004, 22 (5-6) :423-440
[6]   NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses [J].
Autry, Anita E. ;
Adachi, Megunai ;
Nosyreva, Elena ;
Na, Elisa S. ;
Los, Maarten F. ;
Cheng, Peng-fei ;
Kavalali, Ege T. ;
Monteggia, Lisa M. .
NATURE, 2011, 475 (7354) :91-U109
[7]   Conditioned place preference: what does it add to our preclinical understanding of drug reward? [J].
Bardo, MT ;
Bevins, RA .
PSYCHOPHARMACOLOGY, 2000, 153 (01) :31-43
[8]   Antidepressant effects of ketamine in depressed patients [J].
Berman, RM ;
Cappiello, A ;
Anand, A ;
Oren, DA ;
Heninger, GR ;
Charney, DS ;
Krystal, JH .
BIOLOGICAL PSYCHIATRY, 2000, 47 (04) :351-354
[9]  
Birmaher B, 1998, PSYCHOPHARMACOL BULL, V34, P35
[10]   Neurotrophic mechanisms in drug addiction [J].
Bolaños, CA ;
Nestler, EJ .
NEUROMOLECULAR MEDICINE, 2004, 5 (01) :69-83